Now Playing: U.S. prosecutors go after SAC hedge fund for insider trading

U.S. prosecutors have filed their biggest-ever case of insider trading. The allegation: SAC Capital Advisors, a hedge fund, got early warning about the failure of an Alzheimer's drug in clinical trials. That info let the fund sell its holdings in the companies behind the drug, and reap $276 million.